Société Renovaro Inc. Börse Stuttgart
Actions
2Q5
US29350E1047
Recherche biotechnologique et médicale
Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
1,362 EUR | +3,18% | +6,24% | -56,62% |
Métier
Nombre d'employés: 12
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Mark Dybul
CEO | Chief Executive Officer | 60 | 23/01/18 |
Lester Russell
CTO | Chief Tech/Sci/R&D Officer | - | 21/08/23 |
Greg Duczynski
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/16 |
Joseph R. Cohen
CTO | Chief Tech/Sci/R&D Officer | - | - |
François Binette
COO | Chief Operating Officer | - | 20/04/22 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Gregg Alton
BRD | Director/Board Member | 58 | 01/01/20 |
Avram Miller
BRD | Director/Board Member | - | 11/10/23 |
James Sapirstein
BRD | Director/Board Member | 63 | 06/03/18 |
Director/Board Member | 60 | 04/10/23 | |
Director/Board Member | 78 | 04/10/23 | |
Carol Brosgart
BRD | Director/Board Member | 72 | 27/12/19 |
Rene Sindlev
CHM | Chairman | 61 | 18/01/11 |
Mark Dybul
CEO | Chief Executive Officer | 60 | 23/01/18 |
Jayne McNicol
BRD | Director/Board Member | 57 | 25/05/21 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 147 504 944 | 109 814 931 ( 74,45 %) | 0 | 74,45 % |
Action B | 0 | 561 010 | 0 | 0 |
Coordonnées société
Renovaro, Inc.
1927 Paseo Rancho Castillo
90032-2012, Los Angeles
+45 39 17 98 40
http://www.enochianbio.comSecteur
Varia. 1 janv. | Capi. | |
---|---|---|
+11,91% | 118 Md | |
+11,60% | 106 Md | |
-4,68% | 24,28 Md | |
-0,82% | 21,96 Md | |
-10,12% | 18,16 Md | |
-42,12% | 16,37 Md | |
-17,47% | 15,56 Md | |
+2,77% | 13,63 Md | |
+34,58% | 12,27 Md |
- Bourse
- Actions
- Action RENB
- Action 2Q5
- Société Renovaro Inc.